![Derek Yoon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Derek Yoon
Chief Executive Officer at
Solasta Ventures, Inc.
Profile
Derek Yoon currently works at Solasta Ventures, Inc., as President & CEO from 2019, Carbon Biosciences, Inc., as Director, Aju IB Investment Co., Ltd. (Private Equity), as Analyst, and Aju IB Investment US, as Partner.
Mr. Yoon also formerly worked at Clearside Biomedical, Inc., as Independent Director from 2015 to 2017, Trefoil Therapeutics, Inc., as Director from 2015 to 2017, Arcellx, Inc., as Independent Director from 2020 to 2024, Citizens Bank, NA (Providence, Rhode Island), as Portfolio Manager-Healthcare Banking from 2011 to 2013, and Berwind LLC (Massachusetts), as Investment Manager from 2009 to 2011.
Mr. Yoon received his Masters Business Admin degree in 2009 from Babson College, graduate degree in 2011 from Boston College, and undergraduate degree in 1999 from Yonsei University.
Derek Yoon active positions
| Companies | Position | Start |
|---|---|---|
Aju IB Investment US | Corporate Officer/Principal | - |
Solasta Ventures, Inc.
 Solasta Ventures, Inc. Investment ManagersFinance Solasta Ventures invests in companies located in the United States. The firm focuses on information technology, life sciences, therapeutics, pharmaceutical and biotechnology-based sectors. It participates in early-stage capital requirements. | Chief Executive Officer | 01/07/2019 |
Aju IB Investment Co., Ltd. (Private Equity)
 Aju IB Investment Co., Ltd. (Private Equity) Investment ManagersFinance Aju IB is a long-term investor focused on high technology Korean companies with significant growth potential. Aju IB's investment criteria include management's capability, ethics and transparency, potential market leadership or ability to control the market, technological barriers to entry, significant market size, profitability and maturity. They also take into consideration portfolio diversification. | Private Equity Analyst | - |
Carbon Biosciences, Inc.
 Carbon Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops genetic medicines for the treatment of devastating diseases | Director/Board Member | - |
Former positions of Derek Yoon
| Companies | Position | End |
|---|---|---|
| ARCELLX, INC. | Director/Board Member | 18/03/2024 |
| CLEARSIDE BIOMEDICAL, INC. | Director/Board Member | 08/08/2017 |
Trefoil Therapeutics, Inc.
 Trefoil Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company which focuses on the application of novel engineered FGF-1 compounds to treat corneal diseases | Director/Board Member | 01/08/2017 |
Citizens Bank, NA (Providence, Rhode Island)
 Citizens Bank, NA (Providence, Rhode Island) Major BanksFinance Provides commercial banking services | Corporate Officer/Principal | 01/12/2013 |
Berwind LLC (Massachusetts)
 Berwind LLC (Massachusetts) Investment ManagersFinance Berwind invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for early and later stage capital requirements. | Chief Investment Officer | 01/04/2011 |
Training of Derek Yoon
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
86
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Babson College
 Babson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yonsei University
 Yonsei University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aju IB Investment Co., Ltd. (Private Equity)
Aju IB Investment Co., Ltd. (Private Equity) Investment ManagersFinance Aju IB is a long-term investor focused on high technology Korean companies with significant growth potential. Aju IB's investment criteria include management's capability, ethics and transparency, potential market leadership or ability to control the market, technological barriers to entry, significant market size, profitability and maturity. They also take into consideration portfolio diversification. | Finance |
Citizens Bank, NA (Providence, Rhode Island)
Citizens Bank, NA (Providence, Rhode Island) Major BanksFinance Provides commercial banking services | Finance |
Clearside Biomedical, Inc.
 Clearside Biomedical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures suprachoroidal space injections for eye diseases | Health Technology |
Berwind LLC (Massachusetts)
Berwind LLC (Massachusetts) Investment ManagersFinance Berwind invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for early and later stage capital requirements. | Finance |
Arcellx, Inc.
 Arcellx, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies | Health Technology |
Aju IB Investment US | |
Trefoil Therapeutics, Inc.
Trefoil Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company which focuses on the application of novel engineered FGF-1 compounds to treat corneal diseases | Health Technology |
Solasta Ventures, Inc.
Solasta Ventures, Inc. Investment ManagersFinance Solasta Ventures invests in companies located in the United States. The firm focuses on information technology, life sciences, therapeutics, pharmaceutical and biotechnology-based sectors. It participates in early-stage capital requirements. | Finance |
Carbon Biosciences, Inc.
Carbon Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops genetic medicines for the treatment of devastating diseases | Health Technology |
- Stock Market
- Insiders
- Derek Yoon
